{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:29:10Z","timestamp":1794486550121,"version":"4.9.1"},"reference-count":35,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T00:00:00Z","timestamp":1595376000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"name":"Tsukuba Medical Laboratory of Education and Research","award":["26203"],"award-info":[{"award-number":["26203"]}]},{"DOI":"10.13039\/100007449","name":"Takeda Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007449","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005928","name":"Daiwa Securities Health Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005928","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008728","name":"Japan Research Foundation for Clinical Pharmacology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008728","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008731","name":"Nakatomi Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008731","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008734","name":"Mitsui Sumitomo Insurance Welfare Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008734","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Kato Memorial Trust for Nambyo Research"},{"DOI":"10.13039\/100009015","name":"Abbott Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010793","name":"Pfizer Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010793","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Takeda Pharmaceutical"},{"DOI":"10.13039\/501100010486","name":"Teijin Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010486","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Objective<\/jats:title>\n                  <jats:p>Susceptibility genes that can account for characteristic features of SSc such as fibrosis, vasculopathy and autoimmunity remain to be determined. In mice, deficiency of Friend leukaemia integration 1 transcription factor (Fli1) causes SSc-like disease with these features. The human FLI1 gene contains (GA)n microsatellite, which has been shown to be associated with expression level. Because microsatellite polymorphisms are difficult to capture by genome-wide association studies, we directly genotyped FLI1 (GA)n microsatellite and examined its association with SSc.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>Genomic DNA from 639 Japanese SSc patients and 851 healthy controls was genotyped for (GA)n microsatellite using the fragment assay. The cut-off repeat number for susceptibility to SSc was determined by receiver operating characteristics (ROC) analysis. Association with susceptibility and clinical characteristics was examined using logistic regression analysis. FLI1 mRNA levels were determined using quantitative RT-PCR.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Based on the ROC analysis, (GA)n alleles with \u226522 repeats were collectively defined as L alleles and alleles with \u226421 repeats as S alleles. (GA)n L alleles were significantly associated with susceptibility to SSc (P\u2009=\u20095.0e-04, odds ratio 1.34, additive model). Significant association was observed both in diffuse cutaneous and limited cutaneous SSc. Among the SSc, (GA)n L alleles were significantly enriched in the patients with a modified Rodnan total skin thickness score \u226510 compared with those with a score &amp;lt;10. FLI1 mRNA levels were significantly decreased in healthy controls carrying (GA)n L alleles as compared with non-carriers.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Extended repeat alleles of FLI1 (GA)n microsatellite may be associated with lower FLI1 mRNA levels and susceptibility to human SSc.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/rheumatology\/keaa306","type":"journal-article","created":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T11:11:44Z","timestamp":1588849904000},"page":"3553-3562","source":"Crossref","is-referenced-by-count":10,"title":["Association of functional (GA)n microsatellite polymorphism in the FLI1 gene with susceptibility to human systemic sclerosis"],"prefix":"10.1093","volume":"59","author":[{"given":"Keita","family":"Yamashita","sequence":"first","affiliation":[{"name":"Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"},{"name":"Department of Laboratory Medicine, Hamamatsu University School of Medicine, Hamamatsu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Matsushita","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Furukawa","sequence":"additional","affiliation":[{"name":"Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"},{"name":"Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan"},{"name":"Department of Rheumatology, National Hospital Organization Tokyo National Hospital, Kiyose, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuya","family":"Kondo","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5398-0773","authenticated-orcid":false,"given":"Naoko","family":"Okiyama","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhei","family":"Nagaoka","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Yokohama Minami Kyosai Hospital, Yokohama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kota","family":"Shimada","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan"},{"name":"Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Sugii","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Metropolitan Tama Medical Center, Fuchu, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Katayama","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, National Hospital Organization Nagoya Medical Center, Nagoya, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsei","family":"Hirohata","sequence":"additional","affiliation":[{"name":"Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Okamoto","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Hospital Organization Himeji Medical Center, Himeji, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Chiba","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, National Hospital Organization Morioka Medical Center, Morioka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Suematsu","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine and Rheumatology, Clinical Research Institute, National Hospital Organization Kyushu Medical Center, Fukuoka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keigo","family":"Setoguchi","sequence":"additional","affiliation":[{"name":"Allergy and Immunological Diseases, Tokyo Metropolitan Cancer and Infectious Diseases Center Komagome Hospital, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiyoshi","family":"Migita","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Sumida","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeto","family":"Tohma","sequence":"additional","affiliation":[{"name":"Clinical Research Center for Allergy and Rheumatology, National Hospital Organization Sagamihara Hospital, Sagamihara, Japan"},{"name":"Department of Rheumatology, National Hospital Organization Tokyo National Hospital, Kiyose, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhito","family":"Hamaguchi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minoru","family":"Hasegawa","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Fukui, Fukui, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinichi","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Dermatology, University of Tokyo, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Kawaguchi","sequence":"additional","affiliation":[{"name":"Department of Rheumatology, Tokyo Women\u2019s Medical University School of Medicine, Tokyo, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Takehara","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Kanazawa University, Kanazawa, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6776-5580","authenticated-orcid":false,"given":"Naoyuki","family":"Tsuchiya","sequence":"additional","affiliation":[{"name":"Molecular and Genetic Epidemiology Laboratory, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan"},{"name":"Doctoral Program in Biomedical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Tsukuba, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2020,7,22]]},"reference":[{"key":"2020102707010037300_keaa306-B1","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1136\/ard.2006.066068","article-title":"Changes in causes of death in systemic sclerosis, 1972\u20132002","volume":"66","author":"Steen","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"2020102707010037300_keaa306-B2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jaut.2015.07.005","article-title":"Immunogenetics of systemic sclerosis: defining heritability, functional variants and shared-autoimmunity pathways","volume":"64","author":"Bossini-Castillo","year":"2015","journal-title":"J Autoimmun"},{"key":"2020102707010037300_keaa306-B3","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/978-4-431-55708-1_5","volume-title":"Systemic sclerosis","author":"Tsuchiya","year":"2016"},{"key":"2020102707010037300_keaa306-B4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/ng.565","article-title":"Genome-wide association study of systemic sclerosis identifies CD247 as a new susceptibility locus","volume":"42","author":"Radstake","year":"2010","journal-title":"Nat Genet"},{"key":"2020102707010037300_keaa306-B5","doi-asserted-by":"crossref","first-page":"e1002091","DOI":"10.1371\/journal.pgen.1002091","article-title":"Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis","volume":"7","author":"Allanore","year":"2011","journal-title":"PLoS Genet"},{"key":"2020102707010037300_keaa306-B6","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1136\/annrheumdis-2016-210645","article-title":"Transethnic meta-analysis identifies GSDMA and PRDM1 as susceptibility genes to systemic sclerosis","volume":"76","author":"Terao","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"2020102707010037300_keaa306-B7","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.1093\/nar\/gkh906","article-title":"Expression profiles frame the promoter specificity dilemma of the ETS family of transcription factors","volume":"32","author":"Hollenhorst","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"2020102707010037300_keaa306-B8","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am J Pathol"},{"key":"2020102707010037300_keaa306-B9","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1002\/art.21948","article-title":"Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts","volume":"54","author":"Wang","year":"2006","journal-title":"Arthritis Rheum"},{"key":"2020102707010037300_keaa306-B10","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.2353\/ajpath.2010.090593","article-title":"Endothelial Fli1 deficiency impairs vascular homeostasis: a role in scleroderma vasculopathy","volume":"176","author":"Asano","year":"2010","journal-title":"Am J Pathol"},{"key":"2020102707010037300_keaa306-B11","doi-asserted-by":"crossref","first-page":"5797","DOI":"10.1038\/ncomms6797","article-title":"Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis","volume":"5","author":"Noda","year":"2014","journal-title":"Nat Commun"},{"key":"2020102707010037300_keaa306-B12","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.3899\/jrheum.161092","article-title":"Fli1 deficiency induces CXCL6 expression in dermal fibroblasts and endothelial cells, contributing to the development of fibrosis and vasculopathy in systemic sclerosis","volume":"44","author":"Taniguchi","year":"2017","journal-title":"J Rheumatol"},{"key":"2020102707010037300_keaa306-B13","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1016\/j.jid.2017.04.035","article-title":"Systemic sclerosis dermal fibroblasts suppress Th1 cytokine production via galectin-9 overproduction due to Fli1 deficiency","volume":"137","author":"Saigusa","year":"2017","journal-title":"J Invest Dermatol"},{"key":"2020102707010037300_keaa306-B14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1084\/jem.20160247","article-title":"Epithelial Fli1 deficiency drives systemic autoimmunity and fibrosis: possible roles in scleroderma","volume":"214","author":"Takahashi","year":"2017","journal-title":"J Exp Med"},{"key":"2020102707010037300_keaa306-B15","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1111\/exd.13724","article-title":"CXCL13 produced by macrophages due to Fli1 deficiency may contribute to the development of tissue fibrosis, vasculopathy and immune activation in systemic sclerosis","volume":"27","author":"Taniguchi","year":"2018","journal-title":"Exp Dermatol"},{"key":"2020102707010037300_keaa306-B16","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/exd.13341","article-title":"The impact of transcription factor Fli1 deficiency on the regulation of angiogenesis","volume":"26","author":"Toyama","year":"2017","journal-title":"Exp Dermatol"},{"key":"2020102707010037300_keaa306-B17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13075-018-1521-3","article-title":"Fli1-haploinsufficient dermal fibroblasts promote skin-localized transdifferentiation of Th2-like regulatory T cells","volume":"20","author":"Saigusa","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"2020102707010037300_keaa306-B18","doi-asserted-by":"crossref","first-page":"5535","DOI":"10.1038\/sj.onc.1202913","article-title":"The GATA-1 and Spi-1 transcriptional factors bind to a GATA\/EBS dual element in the Fli-1 exon 1","volume":"18","author":"Barbeau","year":"1999","journal-title":"Oncogene"},{"key":"2020102707010037300_keaa306-B19","doi-asserted-by":"crossref","first-page":"R212","DOI":"10.1186\/ar3189","article-title":"A GA microsatellite in the Fli1 promoter modulates gene expression and is associated with systemic lupus erythematosus patients without nephritis","volume":"12","author":"Morris","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"2020102707010037300_keaa306-B20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1038\/gene.2011.37","article-title":"FLI1 polymorphism affects susceptibility to cutaneous leishmaniasis in Brazil","volume":"12","author":"Castellucci","year":"2011","journal-title":"Genes Immun"},{"key":"2020102707010037300_keaa306-B21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/art.1780230510","article-title":"Preliminary criteria for the classification of systemic sclerosis (scleroderma","volume":"23","year":"1980","journal-title":"Arthritis Rheum"},{"key":"2020102707010037300_keaa306-B22","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"LeRoy","year":"1988","journal-title":"J Rheumatol"},{"key":"2020102707010037300_keaa306-B23","first-page":"1892","article-title":"Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies","volume":"20","author":"Clements","year":"1993","journal-title":"J Rheumatol"},{"key":"2020102707010037300_keaa306-B24","doi-asserted-by":"crossref","first-page":"11","DOI":"10.5301\/jsrd.5000231","article-title":"Standardization of the modified Rodnan skin score for use in clinical trials of systemic sclerosis","volume":"2","author":"Khanna","year":"2017","journal-title":"J Scleroderma Relat Disord"},{"key":"2020102707010037300_keaa306-B25","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/1346-8138.14162","article-title":"Diagnostic criteria, severity classification and guidelines of systemic sclerosis","volume":"45","author":"Asano","year":"2018","journal-title":"J Dermatol"},{"key":"2020102707010037300_keaa306-B26","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/bmt.2012.244","article-title":"Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics","volume":"48","author":"Kanda","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"2020102707010037300_keaa306-B27","author":"Gauderman","year":"2001"},{"key":"2020102707010037300_keaa306-B28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/j.1471-8286.2007.01931.x","article-title":"genepop\u2019007: A complete re-implementation of the genepop software for Windows and Linux","volume":"8","author":"Rousset","year":"2008","journal-title":"Mol Ecology Resour"},{"key":"2020102707010037300_keaa306-B29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"2020102707010037300_keaa306-B30","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s004390050480","article-title":"Microsatellite polymorphism in the human heme oxygenase-1 gene promoter and its application in association studies with Alzheimer and Parkinson disease","volume":"100","author":"Kimpara","year":"1997","journal-title":"Hum Genet"},{"key":"2020102707010037300_keaa306-B31","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1086\/302729","article-title":"Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema","volume":"66","author":"Yamada","year":"2000","journal-title":"Am J Hum Genet"},{"key":"2020102707010037300_keaa306-B32","doi-asserted-by":"crossref","first-page":"3388","DOI":"10.1002\/art.23970","article-title":"HMOX1 promoter polymorphism modulates the relationship between disease activity and joint damage in rheumatoid arthritis","volume":"58","author":"Wagener","year":"2008","journal-title":"Arthritis Rheum"},{"key":"2020102707010037300_keaa306-B33","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/aje\/kwu024","article-title":"Association between heme oxygenase 1 gene promoter polymorphisms and susceptibility to coronary artery disease: a HuGE review and meta-analysis","volume":"179","author":"Qiao","year":"2014","journal-title":"Am J Epidemiol"},{"key":"2020102707010037300_keaa306-B34","doi-asserted-by":"crossref","first-page":"e0168210","DOI":"10.1371\/journal.pone.0168210","article-title":"GT)n repeat polymorphism in heme oxygenase-1 (HO-1) correlates with clinical outcome after myeloablative or nonmyeloablative allogeneic hematopoietic cell transplantation","volume":"11","author":"K\u00f8llgaard","year":"2016","journal-title":"PLoS One"},{"key":"2020102707010037300_keaa306-B35","doi-asserted-by":"crossref","first-page":"20839","DOI":"10.1074\/jbc.M010133200","article-title":"Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway","volume":"276","author":"Czuwara-Ladykowska","year":"2001","journal-title":"J Biol Chem"}],"container-title":["Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3553\/34038009\/keaa306.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/rheumatology\/article-pdf\/59\/11\/3553\/34038009\/keaa306.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,27]],"date-time":"2020-10-27T11:43:26Z","timestamp":1603799006000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumatology\/article\/59\/11\/3553\/5874629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,22]]},"references-count":35,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2020,7,22]]},"published-print":{"date-parts":[[2020,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/rheumatology\/keaa306","relation":{},"ISSN":["1462-0324","1462-0332"],"issn-type":[{"value":"1462-0324","type":"print"},{"value":"1462-0332","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,11]]},"published":{"date-parts":[[2020,7,22]]}}}